121 related articles for article (PubMed ID: 1698925)
1. Inhibitory effect of protein kinase C inhibitor on the replication of influenza type A virus.
Kurokawa M; Ochiai H; Nakajima K; Niwayama S
J Gen Virol; 1990 Sep; 71 ( Pt 9)():2149-55. PubMed ID: 1698925
[TBL] [Abstract][Full Text] [Related]
2. Influenza A virus late mRNAs are specifically retained in the nucleus in the presence of a methyltransferase or a protein kinase inhibitor.
Vogel U; Kunerl M; Scholtissek C
Virology; 1994 Jan; 198(1):227-33. PubMed ID: 8259658
[TBL] [Abstract][Full Text] [Related]
3. Failure to obtain drug-resistant variants of influenza virus after treatment with inhibiting doses of 3-deazaadenosine and H7.
Scholtissek C; Müller K
Arch Virol; 1991; 119(1-2):111-8. PubMed ID: 1863219
[TBL] [Abstract][Full Text] [Related]
4. Differential phosphorylation of the nucleoprotein of influenza A viruses.
Kistner O; Müller K; Scholtissek C
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2421-31. PubMed ID: 2778438
[TBL] [Abstract][Full Text] [Related]
5. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.
Martinez-Gil L; Alamares-Sapuay JG; Ramana Reddy MV; Goff PH; Premkumar Reddy E; Palese P
Antiviral Res; 2013 Oct; 100(1):29-37. PubMed ID: 23891991
[TBL] [Abstract][Full Text] [Related]
6. Suppression of c-fos precursor RNA splicing by the protein kinase C inhibitor H7 [1-(5-isoquinolinesulphonyl)-2-methylpiperazine].
Harbers M; Hilz H
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):305-8. PubMed ID: 1909114
[TBL] [Abstract][Full Text] [Related]
7. Silymarin efficacy against influenza A virus replication.
Song JH; Choi HJ
Phytomedicine; 2011 Jul; 18(10):832-5. PubMed ID: 21377857
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of synthesis of virus-specific RNA in cells infected with influenza virus].
Varich NL; Gubareva LV; Kaverin NV
Mol Gen Mikrobiol Virusol; 1988 Nov; (11):35-40. PubMed ID: 3237235
[TBL] [Abstract][Full Text] [Related]
9. [Influenza virus replication in the presence of bonafton and other inhibitors of macromolecular synthesis].
Farashian VR; Gerasina SF; Poliakova IA; Fadeeva NI; Zhdanov VM
Vopr Virusol; 1985; 30(2):174-80. PubMed ID: 4002692
[TBL] [Abstract][Full Text] [Related]
10. Dissection of signals controlling T cell function and activation: H7, an inhibitor of protein kinase C, blocks induction of primary T cell proliferation by suppressing interleukin (IL)2 receptor expression without affecting IL2 production.
Hengel H; Allig B; Wagner H; Heeg K
Eur J Immunol; 1991 Jul; 21(7):1575-82. PubMed ID: 2060574
[TBL] [Abstract][Full Text] [Related]
11. Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro.
Qatsha KA; Rudolph C; Marmé D; Schächtele C; May WS
Proc Natl Acad Sci U S A; 1993 May; 90(10):4674-8. PubMed ID: 7685108
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis of virus-specific RNA in influenza virus-infected cells in the presence of bonafton].
Gerasina SF; Farashian VR; Fadeeva NI; Pershin GN; Zhdanov VM
Farmakol Toksikol; 1985; 48(4):92-5. PubMed ID: 2412888
[No Abstract] [Full Text] [Related]
13. [Protein kinase inhibitor flavopiridol inhibits the replication of influenza virus in vitro].
Wang S; Zhang J; Ye X
Wei Sheng Wu Xue Bao; 2012 Sep; 52(9):1137-42. PubMed ID: 23236848
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
Steele TA; Brahmi Z
J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
[TBL] [Abstract][Full Text] [Related]
15. Divergent activities of protein kinases in IL-6-induced differentiation of a human B cell line.
Goldstein H; Koerholz D; Chesky L; Fan XD; Ambrus JL
J Immunol; 1990 Aug; 145(3):952-61. PubMed ID: 2165096
[TBL] [Abstract][Full Text] [Related]
16. Studies on heterotypic interference between influenza A and B viruses: a differential inhibition of the synthesis of viral proteins and RNAs.
Kaverin NV; Varich NL; Sklyanskaya EI; Amvrosieva TV; Petrik J; Vovk TC
J Gen Virol; 1983 Oct; 64 (Pt 10)():2139-46. PubMed ID: 6619801
[TBL] [Abstract][Full Text] [Related]
17. Biological characterization of FPV, Ulster 73, replicative cycle.
Conti G; Portincasa P; Pesce A; Chezzi C
Microbiologica; 1985 Apr; 8(2):151-64. PubMed ID: 4010527
[TBL] [Abstract][Full Text] [Related]
18. Effect of coumermycin on influenza A virus replicative cycle.
Portincasa P; Palu' G; Conti G; Pesce A; Chezzi C
Microbiologica; 1984 Apr; 7(2):121-32. PubMed ID: 6547762
[TBL] [Abstract][Full Text] [Related]
19. Induction of differentiation of avian erythroblastosis virus-transformed erythroblasts by the protein kinase inhibitor H7: analysis of the transcription factor EF1.
Nicolas RH; Partington G; Major GN; Smith B; Carne AF; Huskisson N; Goodwin G
Cell Growth Differ; 1991 Mar; 2(3):129-35. PubMed ID: 1676294
[TBL] [Abstract][Full Text] [Related]
20. Antiviral effect of Sanicula europaea L. leaves extract on influenza virus-infected cells.
Turan K; Nagata K; Kuru A
Biochem Biophys Res Commun; 1996 Aug; 225(1):22-6. PubMed ID: 8769089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
